References
- Morrow GR, Morrell C. Behavioral treatment for antici-patory nausea and vomiting induced by cancer chemotherapy. N Engl J Med 1982; 307 (24): 1476–1480.
- Laszlo J, Clark RA, Hanson DC, Tyson L, Crumpler L, Grallar R. Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic and anxiolytic effects. J Clin Oncol 1985; 3 (6): 864–869.
- Reyes JG, Fragen RJ, Vinik HR, Greenblat DJ. Midazolam: Pharmacology and uses. Anesthesiology 1985; 62 (3): 310–324.
- Zacny JP, Lichtor JLL, Coalson DW, et al. Subjective and psychomotor effects of subanesthetic doses of propofol in healthy volunteers. Anesthesiology 1992; 76 (5): 696–702.
- Borgeat A, Wilder-Smith OH, Forni M, Suter PM. Adjuvant propofol enables better control of nausea and emesis secondary to chemotherapy for breast cancer. Can J Anaesth 1994; 41 (11): 1117–1119.
- Olynyk JK, Cullen SR, Leahy MF. Midazolam: an effec-tive antiemetic agent for cytotoxic chemotherapy. Med J Aust 1989; 150 (8): 466.
- Potanovich LM, Pisters KM, Kris MG, et al. Midazolam in patients receiving anticancer chemotherapy and antiemet-ics. J Pain Symptom Manage 1993; 8 (8): 519–524.
- Prasad V, Till CB, Smith A. Midazolam, an anti-emetic? Anaesthesia 2002; 57 (4): 415.
- Scher CS, Amar D, McDowall RH, Barst SM. Use of propofol for the prevention of chemotherapy-induced nausea and emesis in oncology patients. Can J Anaesth 1992; 39 (2): 170–172.
- Tomioka S, Kurio T, Takaishi K, Nakajo N. Propofol is effective in chemotherapy induced nausea and vomiting: a case report with quantitative analysis. Anesth Ana1g 1999; 89 (3): 798-799.
- Mackenzie N, Grant IS. Propofol for intravenous seda-tion. Anaesthesia 1987; 42 (1): 3–6.
- Oddby-Muhrbeck E, Eksborg S, Bergendahl HT, Muhrbeck O, Lonqvist PA. Effects of clonidine on postopera-tive nausea and vomiting in breast cancer surgery. Anesthesiology 2002; 96 (5): 1109–1114.
- Bethune DW. Test of delayed memory recall suitable for assessing postoperative amnesia. Anaesthesia 1981; 36 (10): 942–948.
- DiLorenzo TA, Jacobsen PB, Bovbjerg DH, et al. Sources of anticipatory emotional distress in women receiving chemotherapy for breast cancer. Ann Oncol 1995; 6 (7): 705–711.
- Andrykowski MA, Redd WH. Longitudinal analysis of the development of anticipatory nausea. J Consult Clin Psychol 1987; 55 (1): 36–41.
- Bishop JF, Olver IN, Wolf MM, et al. Lorazepam: A randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorop-erazine. J Clin Oncol 1984; 2 (6): 691–695.
- Greenberg DB, Surman OS, Clarke J, et al. Alprazolam for phobic nausea and vomiting related to cancer chemotherapy. Cancer Treat Rep 1987; 71: 549–550.
- Snellen F, Lauwers P, Demeyere R, Byttebier G, Van Aken H. The use of midazolam versus propofol for short-term sedation following coronary artery bypass grafting. Intensive Care Med 1990; 16 (5): 312–316.
- Treish I, Shord S, Valgus J, et al. Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy. Support Care Cancer 2003; 11 (8): 516–521.
- DiFlorio T, Goucke CR. The effect of midazolam on persistent postoperative nausea and vomiting. Anaesth Intensive Care 1999; 27 (1): 38–40.
- PhiIlls JW, Bender AS, Wu PH. Benzodiazepines inhibit adenosine uptake into rat brain synaptosomes. Brain Res 1980; 195 (2): 494–498.
- Takada K, Murai T, Kanayama T, Koshikawa N. Effects of midazolam and flunitrazepam on the release of dopamine from rat striatum measured by in vivo microdialysis. Br J Anaesth 1993; 70 (2): 181–185.